2022 HRO and Safety Education Series - An overview of approaches to cause analysis

May 24, 2022

Presenters will share their processes for triaging and prioritizing safety events for analysis including near misses or no harm events with a high potential for harm or falls or medication events that are higher volume and aggreging causes would be beneficial.

Target Audience




Learning Objectives

1.    Describe how cause analyses (root, apparent, and aggregating) function together to prevent recurrence of loss events, specifically patient harm events.
2.    Apply the five elements of an apparent cause analysis.
3.    Explain how capturing the causal data of the apparent cause analyses enables efficient aggregating analysis.
4.    Discuss the value of contributing and non-contributing factors along with latent failures in improving patient safety.

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE - Attendance
Course opens: 
Course expires: 
Event starts: 
05/24/2022 - 1:00pm CDT
Event ends: 
05/24/2022 - 2:00pm CDT
Live activity
United States

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.


Ineligible companies those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.


FDA Off-Label Use

Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.




Absence of Relevant Financial Relationships

The following planners, faculty, and others in control of educational content have no relevant financial relationships with ineligible companies.


Planning committee members


Ellen Flynn, RN, MBA, JD, CPPS

AVP, Programs



Tammy Williams, MSN, RN, CPPS

Program director



Laura Hoffman, DNP, RN, CPHQ

Program Director



Katy Merkeley, RN, MHSA, PMP, CPPS

Program Director



Jim Lichauer, Pharm.D., BCPS, FASHP

Project Manager, PI Collaboratives & Advisory - Pharmacy



Jay Prystowsky, MD, MBA

Principal, Operations & Quality





Craig Clapper, PE

Executive Advisor

SSM Health


Sumita Markan-Aurora, MBBS, MHA

System Director Patient Safety and Clinical Outcomes

SSM Health


Chellie Butel, RN BSN, JD, MHA

System Director Patient Safety

BJC Healthcare


Donald Krohn, MA, MBA

Performance Improvement/Project Management, Operational Excellence and Transformation Support, Center for Clinical Excellence

BJC Healthcare


Joint Accreditation Statement:

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement:

This activity is designated for 1.00 contact hours.

Vizient, Inc. is approved by the California Board of Registered Nursing, Provider Number CEP12580, for 1.00 contact hours.

Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours. 
Universal Activity Number: JA0006103-0000-22-003-L05-P

Vizient, Inc. designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 CBRN
  • 1.00 General CE - Attendance
Please login or register to take this course.